Mayo Clinic Laboratory and Pathology Research Roundup: Feb. 26 - Insights
This week’s Research Roundup highlights the blast phase myeloproliferative neoplasm with a Mayo-AGIMM study of 410 patients from two separate cohorts.
Regional Health-Mayo Medical Laboratories Collaboration to Benefit Patients, Providers - Insights
Regional Health has selected Mayo Medical Laboratories as its primary reference laboratory. The agreement provides Regional Health Rapid City Hospital physicians and caregivers with access to Mayo Clinic’s extensive menu of more than 4,000...
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.
Disease-specific panels - Insights
Learn how disease-specific cancer panels help providers understand their patients’ risk of having a hereditary cancer syndrome.
01/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Steroid Pathways Mineralocorticoids CYP17A1 = Cytochrome P450 Family 17 Subfamily A Member 1 HSD3B1/HSD3B2 = 3ß Hydroxysteroid...
Communiqué Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.
MCL Genetics Whole Genome Sequencing Flyer MC2775658
MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.
Research Roundup Archives - Page 19 of 28 - Insights
Skip to Content MayoACCESS MayoLINK...